Pierides A M, Aljama P, Kerr D N, Scott M, Norman A W
Nephron. 1978;20(4):203-11. doi: 10.1159/000181223.
Using a 2-hour 47Ca absorption test, significant depression of active calcium absorption was demonstrated in 48 vitamin D untreated haemodialysis patients. This malabsorption of calcium could be corrected by the daily oral administration of 1--2 microgram of 1alphaOHD3 and 1--1.5 microgram of 1,25(OH)2D3. 5 microgram daily for 2 weeks of 3-deoxy-1alphaOHD3 AND 16 and 64 microgram daily for 1 week of 24R,25(OH)2D3 proved ineffective. In 32 successfully transplanted patients, restoration of normal or near normal renal function (serum creatinine less than 1.9 mg/100 ml) was not always followed by an immediate improvement in active calcium absorption. Calcium absorption, especially in female patients, was adversely affected by the required immunosuppressive prednisone therapy and improvement was slow.
采用两小时的47Ca吸收试验,结果显示48例未接受维生素D治疗的血液透析患者存在活性钙吸收显著降低的情况。每日口服1-2微克的1α-羟化胆钙化醇和1-1.5微克的1,25-二羟胆钙化醇可纠正这种钙吸收不良。每日5微克的3-脱氧-1α-羟化胆钙化醇连续服用2周以及每日16和64微克的24R,25-二羟胆钙化醇连续服用1周均证明无效。在32例成功接受移植的患者中,肾功能恢复正常或接近正常(血清肌酐低于1.9毫克/100毫升)并不总是紧接着活性钙吸收立即得到改善。钙吸收,尤其是女性患者的钙吸收,受到所需的免疫抑制性泼尼松治疗的不利影响,改善缓慢。